Navigation Links
Entries Still Open for US Clinical Researcher of the Year 2012 Competition
Date:7/31/2012

LONDON, July 31, 2012 /PRNewswire/ --

There is still time to enter the US Clinical Researcher of the Year competition, whose theme this year focuses on using resources more effectively without compromising patient safety or quality of data.

The competition welcomes participants from the following areas of research:

  • Study Nurse/Clinical Research Coordinator
  • Clinical Research Associates (with varying levels of experience)
  • Project Manager working within a CRO environment
  • Study Leader working within a pharma/sponsor environment
  • Clinical Trial Teams

Entries are building fast with engagement from a broad cross-section of CRO and pharma competitors including: PRA, PPD, Parexel, Chiltern, INC Research, Shire Pharmaceuticals, GSK, Sanofi, Benchmark Research, Endo Pharmaceuticals, MSD, Abbott and Allergan.

Professionals within the clinical research fraternity are able to compete on a level playing field in this competition, working through a series of competency-based exercises that start with a multiple-choice questionnaire based on ICH/GCP and end with a case-study devised to explore different approaches to risk-based or targeted monitoring.

Organised by media company PharmaTimes, the competition is independently judged by a high level Executive Steering Committee drawn from senior pharma clinical leaders within AZ, GSK, MSD, Sanofi, Shire, Endo Pharma, Allergan, Alcon and Stiefel.

Finals day and presentation of the US Clinical Researcher of the Year awards will take place on 8 November and will be hosted by competition sponsors, SAS, at their Executive Briefing Centre in Cary, North Carolina.

Closing date for entry to the competition is 7 September. For more information and/or to enter the competition please go to http://www.usclinicalresearcher.com.

Contacts: Sean Morgan-Jones - +44(0)208-8788566 - email: sean@pharmatimes.com.



'/>"/>
SOURCE Pharma Times
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Call for Entries: International Bureau for Epilepsy and UCB launch the 2012 Excellence in Epilepsy Journalism Award to recognize exceptional reporting on epilepsy
2. Lexicon Pharmaceuticals Reports On Clinical Program Status And 2012 Second Quarter Results
3. Disability Advocates Tell Medicare: Use a Clinical Template to Accurately Document Medical Need for Wheelchairs
4. Jennerex Announces First Patient Treated in Phase 2 Clinical Trial of Intravenous Delivery JX-594 In Patients with Advanced Liver Cancer
5. PRA Participates in Landmark Alzheimers Prevention Clinical Trial
6. Rheumatoid Arthritis New Major Clinical Target After Mesoblast Obtains Positive Results in Inflammatory Arthritis
7. Chimerixs Broad Spectrum Antiviral Therapeutic, CMX001, Demonstrates Potential To Mitigate BK Virus Associated End-Organ Disease In Clinical Study
8. Berg Pharma launches clinical trial on BPM 31543 for prevention of chemotherapy-induced alopecia (CIA)
9. Caspase Inhibitor Enters Clinical Trial In Islet Transplantation As Treatment For Diabetes
10. Boston Scientific Announces Promising Clinical Data on New Products at the International Spine Intervention Society 20th Annual Scientific Meeting
11. Omeros Successfully Completes Preclinical Studies of OMS824 for Schizophrenia and Phase 1 Clinical Trial Preparations Underway
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)... 2017 This report on the opioid induced ... of the global market. Large number of chronic pain ... constipation is a major side effect of consumption of ... targeted therapy has been prescribed to treat opioid induced ... medicines, and growing awareness about the therapy are the ...
(Date:1/19/2017)... -- Accuray Incorporated (Nasdaq: ARAY ) announced ... set the bar for excellence in customer satisfaction. The ... rating among radiation treatment delivery systems in the U.S., ... Briefing™. The most recent ratings trend also shows Accuray ... for 11 of the past 12 quarters. ...
(Date:1/19/2017)... Shire plc (LSE: SHP, NASDAQ: ... and Drug Administration (FDA) has acknowledged receipt of the ... for SHP465, a long-acting, triple-bead, mixed amphetamine salts formulation. ... for Attention-Deficit/Hyperactivity Disorder (ADHD). The FDA is expected to ... the designated Prescription Drug User Fee Act (PDUFA) action ...
Breaking Medicine Technology:
(Date:1/20/2017)... ... 2017 , ... “Christmas in Suffolk”: a story of love, secrets, and ... in Lafayette, Indiana where she works in a daycare and looks for inspiration in ... by Christian Faith Publishing, Sara Seymour’s new book is an adventure of love and ...
(Date:1/20/2017)... ... January 20, 2017 , ... “Knowledge is God’s Lighthouse”: ... faith. “Knowledge is God’s Lighthouse” is the creation of published author, Gene Gaapf, a ... poetry collections. , “I have been writing since high school and have many ...
(Date:1/20/2017)... ... , ... “God's Miracle Man: Against All Odds”: an inspiring affirmation of ... Keith C. A. Tucker, son of Minister Delores Pinnock and a Jamaican native who ... Hardy , “While sitting up in bed, I felt a pounding headache. It was ...
(Date:1/19/2017)... ... January 19, 2017 , ... Aerolib Healthcare ... for Clinical and Regulatory education for Physicians, Physician Advisors, Case managers, Utilization ... methodology of Disease Specific Documentation Improvement. , The Aerolib Learning Management System ...
(Date:1/19/2017)... (PRWEB) , ... January 19, 2017 , ... ... 5,000 SF expansion and facility enhancement of their 503A compounding pharmacy located in ... the growing demand of physicians and patients throughout the United States for high-quality ...
Breaking Medicine News(10 mins):